Posted: 29 October 2024 A study led by researchers from RMIT University and the Doherty Institute has provided the first detailed analysis of how mRNA vaccines circulate and break down in the human bloodstream. The research aimed to…
Posted: 29 October 2024 The Albanese Government is backing Australian business and science, funding world-leading innovations that can help transform Australian industry. More than $55 million in grants for projects working in critical minerals, renewable energy and other…
Posted: 29 October 2024 The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform originally developed by Monash University, has announced the closing of an oversubscribed US$225 million Series B financing round. The funding syndicate was…
Posted: 29 October 2024 Monash University and Yale University, USA, have together received $4M AUD in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS),…
Posted: 29 October 2024 Florey researchers – with Australian research volunteers – have evaluated a new diagnostic blood test for Alzheimer’s and found it to be a reliable measure of the disease’s presence and stage. Plasma pTau217 blood…
Posted: 29 October 2024 Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara®[1]), an agent for the imaging of glioma. The application has been…
Posted: 29 October 2024 4DMedical has been awarded $1.9 million from the Federal Government under the latter’s CRC-P (Cooperative Research Centres Projects) grant program to fund its expansion and ramp-up of clinical trials for CT:VQ, being run in…
Posted: 29 October 2024 Two Australian scientists have each been awarded CSL Centenary Fellowships, valued at $1.25 million over five years. The Fellowships were presented at the Australian Academy of Health and Medical Sciences Annual Meeting on Thursday…
Part A | Tuesday 26 November 2024 BioForum – Biotech scandal to SaaS Success: Fireside chat with Theranos ’survivor’ Marissa Senzaki 03:45 PM Guest arrival and registration
Posted: 21 October 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces that the first part (Part A, single dose) of the…
Posted: 21 October 2024 MTPConnect, Australia’s life science innovation accelerator, and Medical Alley, headquartered in Minnesota have committed to ongoing collaboration to support the growth of medtech companies with the signing today of a Memorandum of Understanding. The…
Posted: 21 October 2024 The Minister for Health and Aged Care, the Hon Mark Butler MP, today announced the successful applicants for the 2024-2027 Support for Cancer Clinical Trials (Clinical Trials) program, with a total of $22.19 million…